ROTTERDAM, Netherlands & FOSTER CITY, Calif.--(BUSINESS WIRE)--Scientists at the Erasmus MC-University Medical Center in Rotterdam, The Netherlands and Applied Biosystems (NYSE:ABI), an Applera Corporation business, have made significant advances in testicular cancer research by identifying and analyzing a set of specific microRNA molecular markers that are involved in the development of testicular tumors. The study, which will be published in the November issue of The Journal of Pathology (Vol. 213 issue 3), provides new information about the unique cellular events that cause testicular cancer. These findings could potentially lead to earlier identification of the disease and new approaches for treating the cancer.
